Literature DB >> 25332519

CD4+ CD56+ Hematodermic Neoplasm Without Cutaneous Involvement.

Seema Sharma1, Chanchal Rana1.   

Abstract

CD4+/CD56+ hematodermic neoplasm is a recently recognized highly aggressive tumor presenting in skin, usually with lymph node and bone marrow involvement, often terminating in a leukemic phase. It has a distinct clinical presentation of primary skin lesions in the form of papules, nodules or bruise like areas. Bone marrow and peripheral blood involvement without skin involvement is a very rare phenomenon. We are reporting an interesting case where an elderly male, a known diabetic, when investigated for the cause of generalised weakness was found to have CD4+/CD56+ hematodermic neoplasm, the unusual feature being absence of any associated cutaneous involvement.

Entities:  

Year:  2012        PMID: 25332519      PMCID: PMC4192233          DOI: 10.1007/s12288-012-0212-5

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  11 in total

1.  Do primary cutaneous non-T non-B CD4+CD56+ lymphomas belong to the myelo-monocytic lineage?

Authors:  M Bagot; A Bouloc; D Charue; J Wechsler; A Bensussan; L Boumsell
Journal:  J Invest Dermatol       Date:  1998-12       Impact factor: 8.551

2.  CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells.

Authors:  Kaaren K Reichard; Eric J Burks; M Kathryn Foucar; Carla S Wilson; David S Viswanatha; John C Hozier; Richard S Larson
Journal:  Am J Surg Pathol       Date:  2005-10       Impact factor: 6.394

Review 3.  CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.

Authors:  Marco Herling; Dan Jones
Journal:  Am J Clin Pathol       Date:  2007-05       Impact factor: 2.493

4.  Clinical and biologic features of CD4(+)CD56(+) malignancies.

Authors:  Jean Feuillard; Marie-Christine Jacob; Françoise Valensi; Marc Maynadié; Rémy Gressin; Laurence Chaperot; Christine Arnoulet; Françoise Brignole-Baudouin; Bernard Drénou; Eliane Duchayne; Annie Falkenrodt; Richard Garand; Emanuelle Homolle; Bernard Husson; Emilienne Kuhlein; Geneviève Le Calvez; Danielle Sainty; Marie-France Sotto; Franck Trimoreau; Marie-Christine Béné
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

5.  CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.

Authors:  Joseph D Khoury; L Jeffrey Medeiros; John T Manning; Laura E Sulak; Carlos Bueso-Ramos; Dan Jones
Journal:  Cancer       Date:  2002-05-01       Impact factor: 6.860

Review 6.  WHO-EORTC classification for cutaneous lymphomas.

Authors:  Rein Willemze; Elaine S Jaffe; Günter Burg; Lorenzo Cerroni; Emilio Berti; Steven H Swerdlow; Elisabeth Ralfkiaer; Sergio Chimenti; José L Diaz-Perez; Lyn M Duncan; Florent Grange; Nancy Lee Harris; Werner Kempf; Helmut Kerl; Michael Kurrer; Robert Knobler; Nicola Pimpinelli; Christian Sander; Marco Santucci; Wolfram Sterry; Maarten H Vermeer; Janine Wechsler; Sean Whittaker; Chris J L M Meijer
Journal:  Blood       Date:  2005-02-03       Impact factor: 22.113

7.  TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin.

Authors:  Marco Herling; Michael A Teitell; Rhine R Shen; L Jeffrey Medeiros; Dan Jones
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

8.  Plasmacytoid T-cell lymphoma associated with chronic myeloproliferative disorder.

Authors:  E F Prasthofer; J T Prchal; W E Grizzle; C E Grossi
Journal:  Am J Surg Pathol       Date:  1985-05       Impact factor: 6.394

9.  High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma.

Authors:  M Adachi; K Maeda; M Takekawa; Y Hinoda; K Imai; S Sugiyama; A Yachi
Journal:  Am J Hematol       Date:  1994-12       Impact factor: 10.047

10.  The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand.

Authors:  G Grouard; M C Rissoan; L Filgueira; I Durand; J Banchereau; Y J Liu
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

View more
  1 in total

1.  Blastic plasmacytoid dendritic cell neoplasm: a rare lymphoma of extremely aggressive course.

Authors:  Magdalena Żychowska; Aleksandra Batycka-Baran; Zdzisław Woźniak; Joanna Maj
Journal:  Postepy Dermatol Alergol       Date:  2017-10-31       Impact factor: 1.837

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.